ABBV/ENTA BID vs. GILD QD. Not to nauseate, but this study disputes the assumption of QD's real world superiority in any event: www.ncbi.nlm.nih.gov/pubmed/17497202 Estimation of the comparative therapeutic superiority of QD and BID dosing regimens, based on integrated analysis of dosing history data and pharmacokinetics. .